BRCA1 and HRR Variants Linked to Improved Survival in Brazilian Triple-Negative Breast Cancer
A study of Brazilian triple-negative breast cancer patients found improved progression-free survival in carriers of BRCA1 and HRR variants alongside ...
A study of Brazilian triple-negative breast cancer patients found improved progression-free survival in carriers of BRCA1 and HRR variants alongside ...
A scientific review highlights how oxidative stress drives cancer progression while exposing therapeutic vulnerabilities that can be targeted through synthetic ...
A study of 77 patients found matrix-producing metaplastic carcinoma of the breast is marked by frequent germline HRD gene variants, ...
New research shows that removing the chromatin remodeler ALC1 sensitizes a broad range of ovarian cancer models to PARP inhibitors ...
A supervised neural network called SuRe outperforms established methods at inferring mutational signature exposures from sparse cancer sequencing data, including ...
A retrospective study in high-grade serous tubo-ovarian carcinoma found that HRDPath inferred homologous recombination deficiency from pathology slides with an ...
A study of 1,009 Chinese breast cancer patients found that BRCA1 mutation carriers had far higher rates of complete tumor ...
New research shows carboplatin drives the expansion of TP53-mutant blood clones far more strongly than PARP inhibitors, while inherited homologous ...
A groundbreaking pan-cancer study published in BMC Cancer unveils the intricate landscape of homologous recombination deficiency (HRD) and homologous recombination ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.